Raven Consulting Group aims to help researchers (at universities, research institutes or within industry) to identify, obtain and maintain funding for their work.
Recce Limited (ASX: RCE) is pioneering the development and commercialisation of a new class of synthetic antibiotics with broad spectrum activity designed to address the urgent global health problem of antibiotic resistant superbugs. Its patented lead candidate known as RECCE® 327 is being developed for the treatment of sepsis derived from S. aureus and E. coli bacteria including their superbug forms.
Redboat helps leaders cut engage, inform and inspire their audiences by delivering strategically and lovingly crafted animation and video campaigns. Helping organisations like CSIRO, Geoscience Australia, the Department of the Environment & Energy, the ATO, Safe Work Australia and The Treasury, Redboat generates large scale engagement with important, complex and sensitive subjects that make a real difference to the lives of Australians.
ReNerve Pty Ltd is a privately held medical devices company specialising in the development of products to transform the repair and replacement of damaged nerves.
Research Australia is an alliance of 160 members and supporters advocating for health and medical research.